Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy
because of their high immunomodulation ability, tropism towards inflamed and injured …

In adults, human mesenchymal stem cells (hMSCs) are found in vivo at low frequency and
are defined by their capacity to differentiate into bone, cartilage, and adipose tissue …

Adipose tissue-derived multipotent stromal cells (AT-MSCs) are studied as an alternative to
bone marrow-derived multipotent stromal cells (BM-MSCs) for immunomodulatory treatment …

Multipotent stromal cells (MSC) have been shown to possess immunomodulatory capacities
and are therefore explored as a novel cellular therapy. One of the mechanisms through …

The inflammatory response to chronic injury affects tissue regeneration and has become an
important factor influencing the prognosis of patients. In previous stem cell treatments, it was …

Mesenchymal stem cells (MSCs) are multi-potent progenitor cells that are isolated from the
bone marrow and several adult organs and tissues. These cells possess remarkable …

Allogeneic mesenchymal stem or stromal cells (MSCs) are proposed as cell therapies for
degenerative, inflammatory, and autoimmune diseases. The feasibility of allogeneic MSC …

There is growing interest in the use of mesenchymal stem cells (MSC) for immune therapy.
Clinical trials that use MSC for treatment of therapy resistant graft versus host disease …

Mesenchymal stem cells (MSCs) are well known for their immunomodulatory capabilities. In
particular, their immunosuppressive property is believed to permit their allogeneic or even …

It is estimated that, of the 7.9 million fractures sustained in the United States each year, 5%
to 20% result in delayed or impaired healing requiring therapeutic intervention. Following …